Andrew Gilbert focuses his practice on corporate finance transactions, mergers and acquisitions and securities law matters. He represents public and private companies primarily in the technology, life sciences and healthcare industries, as well as investment firms that serve these sectors.

Andrew brings clients his extensive background representing issuers, underwriters, and venture capital firms in both public and private offerings. He is highly experienced in securities law compliance and corporate governance matters, with transactional experience in IPOs, PIPEs, registered direct offerings and direct follow-on offerings; as well as in venture capital, private equity, mergers and acquisitions, and other strategic transactions. He also has counseled numerous entrepreneurs and emerging growth companies in planning profitable liquidity strategies. Andrew regularly serves as outside general counsel for private and public companies at various stages of development. 

Andrew is a member of the firm's National Leadership group of the US Emerging Growth and Venture Capital practice.